Cargando…
Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder
OBJECTIVE: Although there are neurobiological studies of patients with generalized anxiety disorder (GAD), the topic is still open to research. Lipid peroxidation can generate new molecular signal sequences by altering protein amounts and activity. 8-Iso-Prostaglandin F2aα (8-iso-PGF2α) is known to...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157002/ https://www.ncbi.nlm.nih.gov/pubmed/37119229 http://dx.doi.org/10.9758/cpn.2023.21.2.370 |
_version_ | 1785036651996643328 |
---|---|
author | Hursitoğlu, Onur Kurutas, Ergül Belge |
author_facet | Hursitoğlu, Onur Kurutas, Ergül Belge |
author_sort | Hursitoğlu, Onur |
collection | PubMed |
description | OBJECTIVE: Although there are neurobiological studies of patients with generalized anxiety disorder (GAD), the topic is still open to research. Lipid peroxidation can generate new molecular signal sequences by altering protein amounts and activity. 8-Iso-Prostaglandin F2aα (8-iso-PGF2α) is known to be an important lipid peroxidation marker. Raftlin, which is defined as a major lipid raft protein, is important for the regulation of signal transduction and inflammatory processes. METHODS: Our aim in this study was to compare the 8-iso-PGF2α and Raftlin levels of forty patients diagnosed with GAD and 40 healthy controls (age-sex and body mass index-matched). RESULTS: In the present study, increased serum 8-iso-PGF2α and Raftlin levels were found in patients with GAD compared to healthy controls. CONCLUSION: To our knowledge, this is the first study to examine 8-iso-PGF2α and Raftlin levels in patients with GAD. These results expand our knowledge of oxidative stress and inflammatory processes in patients with GAD. Our study should be considered preliminary and further studies should be performed with larger sample groups comparing values before and after treatment. |
format | Online Article Text |
id | pubmed-10157002 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Korean College of Neuropsychopharmacology |
record_format | MEDLINE/PubMed |
spelling | pubmed-101570022023-05-30 Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder Hursitoğlu, Onur Kurutas, Ergül Belge Clin Psychopharmacol Neurosci Original Article OBJECTIVE: Although there are neurobiological studies of patients with generalized anxiety disorder (GAD), the topic is still open to research. Lipid peroxidation can generate new molecular signal sequences by altering protein amounts and activity. 8-Iso-Prostaglandin F2aα (8-iso-PGF2α) is known to be an important lipid peroxidation marker. Raftlin, which is defined as a major lipid raft protein, is important for the regulation of signal transduction and inflammatory processes. METHODS: Our aim in this study was to compare the 8-iso-PGF2α and Raftlin levels of forty patients diagnosed with GAD and 40 healthy controls (age-sex and body mass index-matched). RESULTS: In the present study, increased serum 8-iso-PGF2α and Raftlin levels were found in patients with GAD compared to healthy controls. CONCLUSION: To our knowledge, this is the first study to examine 8-iso-PGF2α and Raftlin levels in patients with GAD. These results expand our knowledge of oxidative stress and inflammatory processes in patients with GAD. Our study should be considered preliminary and further studies should be performed with larger sample groups comparing values before and after treatment. Korean College of Neuropsychopharmacology 2023-05-30 2023-05-30 /pmc/articles/PMC10157002/ /pubmed/37119229 http://dx.doi.org/10.9758/cpn.2023.21.2.370 Text en Copyright© 2023, Korean College of Neuropsychopharmacology https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Hursitoğlu, Onur Kurutas, Ergül Belge Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder |
title | Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder |
title_full | Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder |
title_fullStr | Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder |
title_full_unstemmed | Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder |
title_short | Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder |
title_sort | serum levels of 8-iso-prostaglandin f2aα and raftlin in patients with generalized anxiety disorder |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157002/ https://www.ncbi.nlm.nih.gov/pubmed/37119229 http://dx.doi.org/10.9758/cpn.2023.21.2.370 |
work_keys_str_mv | AT hursitogluonur serumlevelsof8isoprostaglandinf2aaandraftlininpatientswithgeneralizedanxietydisorder AT kurutasergulbelge serumlevelsof8isoprostaglandinf2aaandraftlininpatientswithgeneralizedanxietydisorder |